drugset / Trial / NCT02608411
TIvantinib as Maintenance Treatment in Extended Small-cell Lung Cancer (TIMES)
NaSingle-groupOpen-labelTreatment
Summary
This study aims to assess the role of MET inhibitors as maintenance treatment in adult patients with extensive stage small cell lung cancer.
Timeline
- Start
- 2016-02-19
- Primary completion
- 2017-02-21
- Completion
- 2017-02-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tivantinib | Small molecule | 360 mg | Oral |